(Q80781472)
Statements
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance (English)
R Salani
R J Kurman
R Giuntoli
G Gardner
R Bristow
T-L Wang
10 August 2007